» Articles » PMID: 28662088

Automated Interpretation of Influenza Hemagglutination Inhibition (HAI) Assays: Is Plate Tilting Necessary?

Overview
Journal PLoS One
Date 2017 Jun 30
PMID 28662088
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The hemagglutination inhibition assay (HAI) is widely used to evaluate vaccine-induced antibody responses as well as to antigenically characterize influenza viruses. The results of an HAI assay are based on an endpoint titration where the titers are generally manually interpreted and recorded by a well-trained expert. For serological applications, the lack of standardization in endpoint interpretation and interference from non-specific inhibitors in clinical samples can translate into a high degree of variability in the results. For example, tilting HAI plates at 45-60 degrees to look for a "tear drop pattern" with avian red blood cells is a common practice by many, but not all, research laboratories. In this work, we tested the hypothesis that an automated image analysis algorithm can be used to achieve an accurate and non-subjective interpretation of HAI assays-specifically without the need to tilt plates. In a side-by-side comparison study performed during FDA's biannual serological screening process for influenza viruses, titer calls for more than 2200 serum samples were made by the Cypher One automated hemagglutination analyzer without tilting and by an expert human with tilting. The comparison yielded 95.6% agreement between the expert reader and automated interpretation method (within ± 1 dilution) for the complete dataset. Performance was also evaluated relative to the type of red blood cell (turkey and guinea pig) and influenza strain (12 different viruses). For the subset that utilized guinea pig red blood cells (~44% of the samples), for which no plate tilting was required, the agreement with an expert reader was 97.2%. For the subset that utilized turkey red blood cells (~56% of the samples), for which plate tilting was necessary by the expert reader, the agreement was 94.3%. Overall these results support the postulate that algorithm-based interpretation of a digital record with no plate tilting could replace manual reading for greater consistency in HAI assays.

Citing Articles

Enhanced and Prolonged Immunogenicity in Mice of Thermally Stabilized Fatty Acid-Conjugated Vaccine Antigen.

Kim B, Kim Y, Ngo H, Nguyen H, Park C, Lee B Vaccines (Basel). 2025; 13(2).

PMID: 40006715 PMC: 11860450. DOI: 10.3390/vaccines13020168.


A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza Vaccine.

Vincent T, Zhu M, Parekh A, Patel U, Cloney-Clark S, Klindworth A Microorganisms. 2024; 12(11).

PMID: 39597746 PMC: 11596312. DOI: 10.3390/microorganisms12112358.


Intradermal Immunization of Soluble Influenza HA Derived from a Lethal Virus Induces High Magnitude and Breadth of Antibody Responses and Provides Complete Protection In Vivo.

Raj S, Vishwakarma P, Saxena S, Kumar V, Khatri R, Kumar A Vaccines (Basel). 2023; 11(4).

PMID: 37112692 PMC: 10141624. DOI: 10.3390/vaccines11040780.


H3N2 influenza hemagglutination inhibition method qualification with data driven statistical methods for human clinical trials.

Sawant S, Gurley S, Overman R, Sharak A, Mudrak S, Oguin 3rd T Front Immunol. 2023; 14:1155880.

PMID: 37090729 PMC: 10117676. DOI: 10.3389/fimmu.2023.1155880.


Hemagglutinin Antibodies in the Polish Population during the 2019/2020 Epidemic Season.

Szymanski K, Kondratiuk K, Hallmann E, Poznanska A, Brydak L Viruses. 2023; 15(3).

PMID: 36992469 PMC: 10052160. DOI: 10.3390/v15030760.


References
1.
Xie H, Li L, Ye Z, Li X, Plant E, Zoueva O . Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Postvaccination Sera. Clin Infect Dis. 2017; 65(2):259-267. PMC: 5850569. DOI: 10.1093/cid/cix269. View

2.
Nguyen M, Fries K, Khoury R, Zheng L, Hu B, Hildreth S . Automated Imaging and Analysis of the Hemagglutination Inhibition Assay. J Lab Autom. 2015; 21(2):287-96. DOI: 10.1177/2211068215610061. View

3.
Wood J, Gaines-Das R, Taylor J, Chakraverty P . Comparison of influenza serological techniques by international collaborative study. Vaccine. 1994; 12(2):167-74. DOI: 10.1016/0264-410x(94)90056-6. View

4.
Ewing M, Kleven S, Brown M . Comparison of enzyme-linked immunosorbent assay and hemagglutination-inhibition for detection of antibody to Mycoplasma gallisepticum in commercial broiler, fair and exhibition, and experimentally infected birds. Avian Dis. 1996; 40(1):13-22. View

5.
Xie H, Jing X, Li X, Lin Z, Plant E, Zoueva O . Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly. PLoS One. 2011; 6(1):e16650. PMC: 3031605. DOI: 10.1371/journal.pone.0016650. View